U.S. Trade Distributors Stock News

Hut 8 DC LLC, a wholly owned subsidiary of NasdaqGS:HUT, has priced a US$3.25b private offering of senior secured notes. The financing is intended to fund development and construction of a large scale data center at the River Bend campus. The transaction centers on expanding Hut 8's data center and high capacity computing footprint, a key focus area for the business. For investors watching NasdaqGS:HUT, this data center financing highlights how the company is leaning into digital...

Johnson & Johnson (NYSE:JNJ) has received FDA Priority Review for IMAAVY (nipocalimab) for warm autoimmune hemolytic anemia, a rare and life threatening blood disorder with limited treatment options. The FDA has also approved CAPLYTA for relapse prevention in schizophrenia, expanding its use in long term management of this chronic psychiatric condition. These updates reflect meaningful progress in the company’s immunology and neuropsychiatry pipelines within its Innovative Medicine...

Earnings and regulatory updates shape the latest view on CME Group CME Group (CME) just posted first quarter earnings with revenue of US$1,880.1 million and net income of US$1,154.3 million, alongside regulatory approval for an expanded cross margining arrangement with the Depository Trust & Clearing Corporation. See our latest analysis for CME Group. At a share price of US$287.27, CME Group has posted a 6.52% year to date share price return. The 1 year total shareholder return of 7.63% and...

In late April 2026, Goldman Sachs Group issued a wide range of fixed‑income securities, including senior callable and non‑callable notes across multiple currencies, maturities from 2027 to 2051, and both fixed and variable coupons, while also participating as advisor and underwriter in high‑profile capital markets activity such as the anticipated SpaceX IPO. This combination of intensive bond issuance, diversified by tenor and structure, and involvement in very large IPO mandates highlights...

If you are wondering whether Alexandria Real Estate Equities is attractively priced or still a value trap, its current setup raises some important questions worth working through before making any decisions. The share price closed at US$41.05, with returns of a 12.0% decline over 7 days, an 11.3% decline over 30 days, a 16.2% decline year to date, and a 39.8% decline over the past year, which may signal that the market is reassessing both risk and potential reward. Recent headlines around...

Oklo (OKLO) has jumped into focus after announcing a three way collaboration with Nvidia and Los Alamos National Laboratory, aiming to pair its sodium fast reactors with AI infrastructure and nuclear fuel research. See our latest analysis for Oklo. Oklo’s recent Nvidia and Los Alamos agreement came after a sharp 42.6% 1 month share price return, although the share price return is down 16.5% year to date and recent daily moves have been weaker, while the very large 3 year total shareholder...

Enterprise Products Partners (EPD) opened Q1 2026 with revenue of US$14.4b and basic EPS of US$0.68, alongside net income of US$1.5b, setting the tone for a steady start to the year. Over the past year of reported quarters, revenue has moved between US$11.4b and US$15.4b while quarterly EPS ranged from about US$0.61 to US$0.75, giving you a clear view of how the top line and per unit earnings have been tracking through different market conditions. With net profit margins recently higher than...

If you are wondering whether Fidelity National Information Services' current share price reflects its true worth, this article focuses squarely on what the numbers say about value. The stock last closed at US$46.22, with returns of a 3.4% decline over 7 days, a 2.6% decline over 30 days, a 29.6% decline year to date and a 39.9% decline over the past year, which may prompt questions about risk and potential upside. Recent coverage has focused on how investors are reassessing payments and...

Why Teva’s latest earnings are back in focus Teva Pharmaceutical Industries (NYSE:TEVA) is back on investor radar after first quarter 2026 results. The company reported higher net income and operating income, provided fresh biosimilar updates, and highlighted stronger UZEDY sales alongside a new schizophrenia NDA filing. See our latest analysis for Teva Pharmaceutical Industries. The strong first quarter update, FDA progress for biosimilars, and Emalex deal have come alongside sharp gains,...

Enphase Energy (ENPH) has kicked off Q1 2026 with revenue of US$282.9 million and basic EPS of a US$0.06 loss, compared with Q1 2025 revenue of US$356.1 million and basic EPS of US$0.23, setting a very different tone to last year’s opening quarter. Over the past year, the company has seen revenue move from US$1.33 billion in the trailing twelve months to Q4 2024 to US$1.40 billion in the trailing twelve months to Q1 2026, while trailing EPS shifted from US$0.76 to US$1.03, giving you a mixed...

CDW (NasdaqGS:CDW) has appointed Hang Tan as Chief Strategy and Transformation Officer. Tan joins from Hewlett Packard Enterprise, bringing experience in hybrid cloud, corporate transformation, and large scale technology operations. CDW, trading at $135.56, has seen a mixed share price record, with a 12.0% return over the past 30 days but a 15.1% decline over the past year. For investors tracking leadership signals, the addition of a senior executive with broad cloud and transformation...

Citizens Financial Group reported past first-quarter 2026 results showing net interest income of US$1,562 million and net income of US$517 million, with diluted EPS from continuing operations of US$1.13 and net charge-offs reduced to US$138 million, while also declaring a US$0.46 per-share quarterly dividend payable in May 2026. The combination of higher earnings and lower net charge-offs points to improved profitability and credit costs, which may reassess how investors view the bank’s...

University of Washington partnership puts Evolv in focus Evolv Technologies Holdings (EVLV) gained fresh attention after agreeing to a multi-year subscription and marketing partnership with the University of Washington, which plans to roll out Evolv Express Gen2 systems across major campus athletic venues. See our latest analysis for Evolv Technologies Holdings. The University of Washington partnership comes as momentum has been building, with a 16.2% 1 month share price return and a 67.38% 1...

Earlier this month, Axon Enterprise unveiled three AI-powered public safety tools, Axon Vision, an expanded Axon Assistant, and Axon 911, at its Axon Week 2026 conference, aiming to help agencies manage data overload and improve emergency response workflows. Axon 911, a cloud-based AI infrastructure for emergency call centers, stands out because it embeds Axon's software deeper into mission-critical public safety systems, potentially increasing the stickiness of its platform with government...

If you are wondering whether Kratos Defense & Security Solutions is still priced attractively after a strong run, this article walks through what the current share price might be implying about value. The stock most recently closed at US$59.56, with returns of 70.5% over 1 year, 122.7% over 5 years, and a very large gain over 3 years. However, the year-to-date return shows a 24.9% decline, and shorter term moves include a 9.1% decline over 7 days and a 15.5% decline over 30 days. These...

Why Graphic Packaging Holding (GPK) Has Drawn Fresh Attention Graphic Packaging Holding (GPK) is back on investors’ radar after a sharp share price reset over the past 3 months, with the stock now around $9.60 and recent returns mixed across timeframes. See our latest analysis for Graphic Packaging Holding. The recent reset has come after a steep 90 day share price return of around 34% decline and a year to date share price return of about 37% decline. The 1 year total shareholder return of...

In April 2026, Core Scientific Finance I LLC completed a US$3.30 billion offering of senior secured, guaranteed notes due 2031, alongside Core Scientific Inc.’s push to repurpose its Pecos, Texas site into a roughly 1.5 gigawatt AI-focused data center campus. These moves, together with expanded institutional interest and long-term AI infrastructure partnerships, highlight Core Scientific’s accelerating shift away from Bitcoin mining toward high-performance computing and AI hosting. Next,...

The PNC Financial Services Group has recently filed a US$6.43 billion shelf registration for 29,260,000 common shares tied to an ESOP offering, while also reporting solid first-quarter 2026 results supported by legacy loan growth and technology-focused expansion plans. At the same time, PNC is broadening its Treasury Management insurance payments platform through a collaboration with ECHO Health, aiming to streamline complex claims processing for large insurers and deepen its presence in...

Some investors may be wondering if Amneal Pharmaceuticals at around US$12.80 is still reasonably priced after a strong run, or if the easier gains are already behind it. The stock has recent returns of 1.2% over 7 days, 3.0% over 30 days, 1.1% year to date and 65.4% over the last year, with a very large 3 year gain and a 121.5% return over 5 years. Recent coverage has focused on Amneal Pharmaceuticals as a generic and specialty pharmaceuticals player, with attention on its role in supplying...

Planet Labs PBC has adopted VyOS Networks to support resilient hybrid networking across its satellite data platform. The deployment is designed to provide high availability, secure connectivity and flexible routing across Planet Labs' global operations. This IT rollout is a fresh operational development for NYSE:PL that has not been widely covered in recent commentary. For investors tracking NYSE:PL, this VyOS deployment speaks directly to the plumbing that keeps Planet Labs' geospatial...

Iovance Biotherapeutics recently proposed amending its Certificate of Incorporation to lift its authorized common stock cap from 500,000,000 to 650,000,000 shares, with shareholders set to vote on the change at the June 10, 2026 annual meeting. The move to expand authorized shares, alongside upcoming first-quarter 2026 results and a corporate update call on May 7, highlights how Iovance is preparing for future capital and growth initiatives around its TIL therapy platform. Next, we’ll...

Stock performance snapshot and context Marsh & McLennan Companies (MRSH) has seen mixed share performance recently, with a small 1 day move, weaker returns over the past week and month, and a deeper decline over the past 3 months. Over the year to date and past year, the stock shows negative total returns, while the 3 year and 5 year periods remain positive. This provides a contrast between shorter term pressure and longer term compounding. See our latest analysis for Marsh & McLennan...

With NIKE at a last close of US$44.39, investors may be asking whether that price still reflects the strength of its brand or whether the stock is pricing in too much caution. This article focuses squarely on what you are getting for that price. Recent share price moves, including a 2.8% decline over the last 7 days, a 13.4% decline over 30 days, and a 29.9% decline year to date, have sharpened questions about both risk and potential upside, especially given the 19.3% 1 year and 62.9% 3 year...

NETSTREIT (NTST) has been busy, pairing fresh first quarter results and a higher dividend with substantial equity issuance. This includes a completed US$236.1m at the market offer and a new US$400m program. See our latest analysis for NETSTREIT. The follow on equity offerings and stronger first quarter figures appear to sit behind a solid run in NETSTREIT’s 30 day share price return of 8.04%, while the 1 year total shareholder return of 32.60% and 3 year total shareholder return of 34.41%...